Chris is the Vice President of Business Development at CytoSorbents, a critical care company specializing in blood purification to control deadly inflammation in critically-ill and cardiac surgery patients. Previously, he was Senior Director of New Venture Development at Johnson & Johnson (J&J). Prior to that, he was the Worldwide Strategic Marketing leader responsible for developing and executing branding and business development strategies for J&J’s minimally invasive weight-loss surgery division. Prior to J&J, he held multiple leadership positions at PwC Consulting and Parametric Technology Corporation. Chris earned his BS degree from Miami University and MBA and MS degrees from Carnegie Mellon University. He joined Isles’ Board of Trustees in 2017.